Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

The next big advance in cancer treatment could be a vaccine

by AIP Online Bureau | Jun 26, 2023 | Eco/Invest/Demography, Facts, Health

Drugmakers Moderna and Merck are jointly developing a personalized mRNA vaccine for patients with melanoma, with a large study to begin this year. The vaccines are customized to each patient, based on the numerous mutations in their cancer tissue After decades of...

How anti-vaccine misinformation hampers the conversation about genuine vaccine injuries

by AIP Online Bureau | Jan 16, 2023 | Facts, Health, Pandemic

In very rare cases though, vaccines can be linked to serious injuries and even death. Vaccine injuries (also often called adverse events) are a difficult area in which to carry out research or advocacy, partly because anti-vaccine communities persistently muddy the...
Year-ender 2022: Despite vaccine strides, India not out of Covid-19 shadow yet

Year-ender 2022: Despite vaccine strides, India not out of Covid-19 shadow yet

by AIP Online Bureau | Dec 31, 2022 | Eco/Invest/Demography, Health, Indian News, Pandemic

“Currently, there are 10 different variants of Covid-19 in the country, with the latest being BF.7. The Delta variant of Covid-19 is also around in the country,” a source told ANI. The sudden surge in Covid cases in the United States, China, Brazil and...

Vaccine against cervical cancer to be included in national immunisation programme by mid-2023: NTAGI chief

by AIP Online Bureau | Dec 15, 2022 | Eco/Invest/Demography, Facts, Health, Policy

India is home to about 16 per cent of the world’s women and accounts for about a quarter of all cervical cancer incidences and nearly a third of global cervical cancer deaths. Indian women face a 1.6 per cent lifetime cumulative risk of developing cervical...

DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use

by AIP Online Bureau | Sep 7, 2022 | Health, Indian News, Pandemic

”Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for...
« Older Entries
Next Entries »

Recent Posts

  • Air India’s Ahmedabad Crash:Re/insurers clear $125 million claims for AI’s Hull and engines
  • ICICI Foundation partners with IIT Kanpur to build Digital Health Stack
  • India projected to grow 6.4% in 2025 & 2026, reform momentum driving stable growth: IMF
  • Microsoft restores services to Nayara ahead of HC hearing
  • International Road Federation flags safety non-adherence in road projects in India

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy